197 related articles for article (PubMed ID: 17364892)
1. Chemokine transport across human vascular endothelial cells.
Mordelet E; Davies HA; Hillyer P; Romero IA; Male D
Endothelium; 2007; 14(1):7-15. PubMed ID: 17364892
[TBL] [Abstract][Full Text] [Related]
2. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
[TBL] [Abstract][Full Text] [Related]
3. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis.
Tanuma N; Sakuma H; Sasaki A; Matsumoto Y
Acta Neuropathol; 2006 Aug; 112(2):195-204. PubMed ID: 16733654
[TBL] [Abstract][Full Text] [Related]
4. The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1alpha, MIP-1beta, IP-10)-positive cells in human periapical granulomas.
Kabashima H; Yoneda M; Nagata K; Hirofuji T; Ishihara Y; Yamashita M; Maeda K
Cytokine; 2001 Oct; 16(2):62-6. PubMed ID: 11683586
[TBL] [Abstract][Full Text] [Related]
5. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2.
Dzenko KA; Song L; Ge S; Kuziel WA; Pachter JS
Microvasc Res; 2005 Jul; 70(1-2):53-64. PubMed ID: 15927208
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXC chemokine IP-10 in testicular germ cell tumours.
Schweyer S; Soruri A; Baumhoer D; Peters J; Cattaruzza M; Radzun HJ; Fayyazi A
J Pathol; 2002 May; 197(1):89-97. PubMed ID: 12081209
[TBL] [Abstract][Full Text] [Related]
7. CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II.
Pechkovsky DV; Goldmann T; Ludwig C; Prasse A; Vollmer E; Müller-Quernheim J; Zissel G
Respir Res; 2005 Jul; 6(1):75. PubMed ID: 16033640
[TBL] [Abstract][Full Text] [Related]
8. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
[TBL] [Abstract][Full Text] [Related]
9. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration.
Hillyer P; Mordelet E; Flynn G; Male D
Clin Exp Immunol; 2003 Dec; 134(3):431-41. PubMed ID: 14632748
[TBL] [Abstract][Full Text] [Related]
10. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
[TBL] [Abstract][Full Text] [Related]
11. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
[TBL] [Abstract][Full Text] [Related]
12. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
[TBL] [Abstract][Full Text] [Related]
13. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
14. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase.
Stamatovic SM; Keep RF; Kunkel SL; Andjelkovic AV
J Cell Sci; 2003 Nov; 116(Pt 22):4615-28. PubMed ID: 14576355
[TBL] [Abstract][Full Text] [Related]
15. Transcellular transport of CCL2 across brain microvascular endothelial cells.
Ge S; Song L; Serwanski DR; Kuziel WA; Pachter JS
J Neurochem; 2008 Mar; 104(5):1219-32. PubMed ID: 18289346
[TBL] [Abstract][Full Text] [Related]
16. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
Soejima K; Rollins BJ
J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
[TBL] [Abstract][Full Text] [Related]
17. Cellular characteristics of neuroblastoma cells: regulation by the ELR--CXC chemokine CXCL10 and expression of a CXCR3-like receptor.
Goldberg-Bittman L; Sagi-Assif O; Meshel T; Nevo I; Levy-Nissenbaum O; Yron I; Witz IP; Ben-Baruch A
Cytokine; 2005 Feb; 29(3):105-17. PubMed ID: 15613278
[TBL] [Abstract][Full Text] [Related]
18. Effect of blocking the CXCL9/10-CXCR3 chemokine system in the outcome of endothelial-target rickettsial infections.
Valbuena G; Walker DH
Am J Trop Med Hyg; 2004 Oct; 71(4):393-9. PubMed ID: 15516632
[TBL] [Abstract][Full Text] [Related]
19. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13.
Stich S; Loch A; Leinhase I; Neumann K; Kaps C; Sittinger M; Ringe J
Eur J Cell Biol; 2008 Jun; 87(6):365-76. PubMed ID: 18501472
[TBL] [Abstract][Full Text] [Related]
20. Identification of potent and selective RNA antagonists of the IFN-gamma-inducible CXCL10 chemokine.
Marro ML; Daniels DA; McNamee A; Andrew DP; Chapman TD; Jiang MS; Wu Z; Smith JL; Patel KK; Gearing KL
Biochemistry; 2005 Jun; 44(23):8449-60. PubMed ID: 15938634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
